Clinical Trials
5
Active:3
Completed:1
Trial Phases
2 Phases
Phase 1:3
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (60.0%)Phase 2
2 (40.0%)A Study to Investigate the Efficacy and Tolerability of ESO-101 in Patients With Eosinophilic Esophagitis
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2023-11-14
- Lead Sponsor
- EsoCap AG
- Target Recruit Count
- 43
- Registration Number
- NCT04849390
- Locations
- 🇩🇪
Facharztzentrum Eppendorf, Hamburg, Germany
🇩🇪Universitätsklinikum Leipzig AöR, Leipzig, Germany
🇩🇪Otto-von-Guericke-Universität Medizinische Fakultät Universitätsklinikum Magdeburg A. ö. R., Magdeburg, Germany
News
No news found